Mrinali Gupta, MD
Ophthalmology · New York, NYNPI 1902037047
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $165,625 of the $181,523 with a category attached, or 91.2%. Alcon accounts for 70.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $49,746 and has fallen 71.9% since, to $14,002 in 2025. Among ophthalmology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $1251.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$128K
- Alcon Research LLC$33K
- AbbVie$9K
- Carl Zeiss Meditec, Inc.$7K
- Alimera Sciences, Inc.$2K
- Ocular Therapeutix, Inc.$2K
- plus $2K from 11 others
What the payments were for
- Consulting fees$165,62591%
- Speaking & faculty fees$4,9403%
- Travel & lodging$5,5423%
- Food & beverage$5,3473%
- Education$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 53 | $127,765 |
| Alcon Research LLC | 12 | $32,606 |
| AbbVie(2 entities) | 22 | $8,855 |
| Carl Zeiss Meditec, Inc. | 6 | $6,765 |
| Alimera Sciences, Inc. | 15 | $1,673 |
| Ocular Therapeutix, Inc. | 1 | $1,600 |
| Eyepoint US, Inc. | 4 | $515 |
| Genentech USA, Inc. | 7 | $438 |
| Regeneron Healthcare Solutions, Inc. | 6 | $418 |
| Astellas Pharma US Inc | 8 | $230 |
| Apellis Pharmaceuticals, Inc. | 4 | $207 |
| Spark Therapeutics, Inc. | 1 | $125 |
| Genentech, Inc. | 1 | $115 |
| Glaukos Corporation | 1 | $113 |
| Amgen | 2 | $69 |
| Coherus Oncology, Inc. | 1 | $28 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$63,040
- NGENUITY$45,353
- FINESSE SHARKSKIN$13,553
- AcrySof$13,300
- OZURDEX$8,156
- Unity$7,651
- ARGOS$6,300
- CIRRUS HD-OCT$5,440
- Retina Workplace$3,740
- Iluvien$1,311
- FORUM$1,020
- Humphrey HFA$680
- IOLMaster 700$680
- VERACITY SURGICAL$680
- VisuMax$680
- YUTIQ$515
- VABYSMO$425
- EYLEA HD$219
- VUITY$123
- iStent inject W$113
How this compares
$181,523 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 212 | $6,395 |
| MoxifloxacinMoxifloxacin Hcl | 99 | $2,393 |
| Atropine Sulfate | 51 | $1,891 |
| Brimonidine Tartrate | 16 | $1,771 |
| Ketorolac Tromethamine | 84 | $1,290 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 35 | $600 |
| Dorzolamide Hcl | 11 | $250 |
| Latanoprost | 21 | $159 |
| Timolol Maleate | 18 | $137 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in New York
- Nathan RadcliffeNew York$2.1M
- Richard SpaideNew York$1.7M
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$541K
- Eric RosenbergNew York$434K
- Michael CooneyNew York$398K
- David GuyerNew York$322K
- Ashley BrissetteNew York$315K
- Jason SlakterNew York$272K
- David ChuNew York$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.